Selskabets formål er udvikling og salg af medical devices samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 190.9 mio. | 36.8 mio. | 123.6 mio. | 81.9 mio. | 69 | |
CVR: 29411166
Secondary names: MBH-INTERNATIONAL A/S
Previous names: MBH-INTERNATIONAL ApS, MBH-INTERNATIONAL A/S
Morten Højland Boesen joined as director
Michael Molbech Sorth left as director
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Qufora A/S demonstrates a strong financial health with a notable increase in revenue and profitability over the past few years. In 2024, the company achieved a revenue of 190.9 million DKK and a profit of 36.8 million DKK, reflecting a significant growth from 157.8 million DKK in revenue and 44.5 million DKK in profit in 2023. The profit margin has shown fluctuations, but overall, the trend is positive, with profits rising from 8.9 million DKK in 2022 to 36.8 million DKK in 2024. The equity position of 81.9 million DKK indicates a solid foundation, although the lack of equity data for some years raises concerns about consistency. Positioned within the wholesale trade of medicinal products and healthcare articles, Qufora A/S is well-placed in a growing industry, benefiting from increasing demand for healthcare solutions.
AI-generated summary
Companies in the same industry and area
companydata.dk